DK1007097T3 - Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler - Google Patents

Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler

Info

Publication number
DK1007097T3
DK1007097T3 DK98906986T DK98906986T DK1007097T3 DK 1007097 T3 DK1007097 T3 DK 1007097T3 DK 98906986 T DK98906986 T DK 98906986T DK 98906986 T DK98906986 T DK 98906986T DK 1007097 T3 DK1007097 T3 DK 1007097T3
Authority
DK
Denmark
Prior art keywords
nucleic acid
formulation
acid particles
transfection agents
cationic transfection
Prior art date
Application number
DK98906986T
Other languages
Danish (da)
English (en)
Inventor
Bruno Pitard
Joel Crouzet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1007097(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1007097T3 publication Critical patent/DK1007097T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK98906986T 1997-02-10 1998-02-06 Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler DK1007097T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
PCT/FR1998/000222 WO1998034648A1 (fr) 1997-02-10 1998-02-06 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
DK1007097T3 true DK1007097T3 (da) 2002-02-11

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98906986T DK1007097T3 (da) 1997-02-10 1998-02-06 Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler

Country Status (20)

Country Link
EP (1) EP1007097B1 (de)
JP (1) JP2001511171A (de)
KR (1) KR20000070914A (de)
AT (1) ATE206932T1 (de)
AU (1) AU737720B2 (de)
BR (1) BR9807563A (de)
CA (1) CA2278665A1 (de)
CZ (1) CZ282199A3 (de)
DE (1) DE69802102T2 (de)
DK (1) DK1007097T3 (de)
ES (1) ES2166146T3 (de)
FR (1) FR2759298B1 (de)
GR (1) GR3036919T3 (de)
HU (1) HUP0001720A3 (de)
IL (1) IL130765A0 (de)
NO (1) NO993825L (de)
PT (1) PT1007097E (de)
SK (1) SK282685B6 (de)
WO (1) WO1998034648A1 (de)
ZA (1) ZA981034B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
JP2002511446A (ja) * 1998-04-08 2002-04-16 セルテック・セラピューティクス・リミテッド 脂 質
EP1096921B1 (de) * 1998-07-20 2003-04-16 Protiva Biotherapeutics Inc. In liposomen verkapselte nukleinsäurekomplexe
BR0108959A (pt) * 2000-03-03 2003-10-14 Valentis Inc Composições de polox‰mero ou poloxamina melhoradas para distribuição de ácido nucléico
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
CA2426582A1 (en) * 2000-10-20 2002-08-08 Valentis, Inc. Gene delivery formulations and methods for treatment of ischemic conditions
EP1232758A1 (de) * 2001-02-19 2002-08-21 Aventis Pasteur Polynukleotid-Formulierung für verbesserte intrazellulare Übertragung
JP2007527431A (ja) 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP2008531732A (ja) 2005-03-03 2008-08-14 ルバンス セラピュティックス インク． ボツリヌス毒素の局所塗布及び経皮送達のための組成物及び方法
JP4653242B1 (ja) * 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (de) * 1994-08-09 2004-02-04 Cytrx Corporation Nukleinsäure enthaltender Impfstoff, Impfstoff-adjuvans
AU5527696A (en) * 1995-03-31 1996-10-16 Children's Hospital Medical Center Use of surfactants for introducing genetic material into lun g cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
AU6298798A (en) 1998-08-26
HUP0001720A3 (en) 2001-10-29
FR2759298B1 (fr) 1999-04-09
DE69802102T2 (de) 2002-03-14
ES2166146T3 (es) 2002-04-01
SK108299A3 (en) 2000-05-16
BR9807563A (pt) 2000-02-01
CA2278665A1 (fr) 1998-08-13
WO1998034648A1 (fr) 1998-08-13
AU737720B2 (en) 2001-08-30
PT1007097E (pt) 2002-04-29
DE69802102D1 (de) 2001-11-22
KR20000070914A (ko) 2000-11-25
NO993825D0 (no) 1999-08-09
ATE206932T1 (de) 2001-11-15
EP1007097B1 (de) 2001-10-17
EP1007097A1 (de) 2000-06-14
FR2759298A1 (fr) 1998-08-14
JP2001511171A (ja) 2001-08-07
GR3036919T3 (en) 2002-01-31
SK282685B6 (sk) 2002-11-06
HUP0001720A1 (hu) 2000-09-28
IL130765A0 (en) 2001-01-28
ZA981034B (en) 1998-08-11
CZ282199A3 (cs) 1999-10-13
NO993825L (no) 1999-08-09

Similar Documents

Publication Publication Date Title
DK1007097T3 (da) Formulering af stabiliserede kationiske transfektionsmidler/nucleinsyrepartikler
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
EP0911039A3 (de) Wirkstoff-Harzkomplexe stabilisiert mit Chelatbildner
FR2791895B1 (fr) Utilisation de trehalose pour stabiliser un vaccin liquide
PT1123120E (pt) Formulacao medicinal em aerossol
TR199501321A2 (tr) Farmasötik bilesimler.
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
DK1158959T3 (da) Sammensætninger og fremgangsmåder til forbedret indgift af hydrofobe terapeutiske midler
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
ZA986475B (en) Thermodynamically stable modification of 1-(4-carbazoly loxy)3-[2-)2-methoxyphenoxy)ethylamino]-2-propanole, and pharmaceutical compositions containing it.
BR0207699A (pt) Produto para aplicação axilar
BR0015538A (pt) Emprego de polissiloxanos com grupos amino quaternários como coadjuvantes de formulação, e agentes contendo-os
BE1014502A5 (fr) Compositions pharmaceutiques.
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
ATE174955T1 (de) Stabile, nichtionische tensidemulsionen, welche viskositätskontrollmittel enthalten
ES2179508T3 (es) Composicion cosmetica que comprende una amida y nuevas amidas.
TR199801460T2 (xx) Renk stabilize edici(ler) ve s�rfaktan(lar)� i�eren temizleyici bile�im.
BR9811985A (pt) Dispositivo de dosagem
DE69429252T2 (de) Fluessige arzneizusammensetzungen enthaltend ibuprofen
HUP0202378A3 (en) Surfactant mixture, emulsion containing thereof structured surfactant composition and detergent composition
WO1999055634A8 (en) Superfluidifying additive for cementitious compositions
ATE310075T1 (de) Reinigungsmittelkomponente mit feinteiligen feststoffen
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid